Hemoglobin or Epo Dose: Which Poses Heart Risk?

George Bakris talked to Peter McCullough about the role of hemoglobin and erythropoietin in cardiovascular events in patients with chronic kidney disease.

Source: Medscape Cardiology Podcast - August 7, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts